Regeneron will not acquire 23andMe's Lemonaid Health telehealth business. "We have deep experience with large-scale data management," Regeneron co-founder George Yancopoulos said in a statement.

Details about Regeneron purchasing 23andMe The transaction remains subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri. If approved, it is expected to close in ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday.

Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy auction, and promised to prioritize the ethical use of DNA data from ...

Regeneron’s purchase does not include 23andMe’s Lemonaid Health business. Additional details about the company’s operating plans will be shared at time of closing, the company said.

Regeneron Pharmaceuticals said it will acquire 23andMe's business. What happened to 23andMe? Should you delete your data? What to know.

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. Picture taken September 17, 2020.

Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million© george frey/Reuters 23andMe’s DNA-testing kits made a splash years ago, leading to the company going public in 2021.© george frey ...